Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    "Epidermolysis Bullosa" OR "epidermolysis bullosa with pyloric atresia"
Show Display Options
Rank Status Study
21 Not yet recruiting Diacerin for the Treatment of Epidermolysis Bullosa Simplex
Condition: Epidermolysis Bullosa Simplex
Intervention: Drug: Diacerin cream
22 Terminated Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
23 Completed Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)
Condition: Epidermolysis Bullosa Dystrophica
Interventions: Drug: Polyphenon E before Placebo;   Drug: placebo before treatment
24 Completed Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa With Mitten Hands
Intervention: Biological: Cell transplantation
25 Recruiting Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
26 Completed Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Intervention:
27 Completed Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Drug: Granulocyte Colony Stimulating Factor (GCSF)
28 Recruiting Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Intervention: Genetic: LZRSE-Col7A1 Engineered Autologous Epidermal Sheets (LEAES)
29 Completed
Has Results
Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Interventions: Device: Helicoll;   Device: Standard of Care Dressings
30 Recruiting A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Epidermolysis Bullosa Dystrophica, Recessive
Interventions: Genetic: FCX-007;   Drug: Sterile Saline
31 Recruiting Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa
Condition: Recessive Dystrophic Epidermolysis Bullosa
Intervention: Drug: Mesenchymal stromal cells
32 Recruiting Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa
Condition: Recessive Dystrophic Epidermolysis Bullosa
Intervention: Drug: Gene-modified autologous fibroblasts
33 Unknown  Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Recessive Dystrophic Epidermolysis Bullosa
Interventions: Other: Blood collection;   Other: Skin biopsies
34 Active, not recruiting Clinical Trial to Assess the Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified for Restoration of Epidermis in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Condition: Recessive Dystrophic Epidermolysis Bullosa
Intervention: Other: ATMP - transplantable cultured epidermal sheets prepared from autologous transduced epidermal keratinocytes including epidermal stem cells on a fibrin support
35 Terminated
Has Results
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
Conditions: Epidermolysis Bullosa, Junctional;   Epidermolysis Bullosa Dystrophica
Interventions: Device: Apligraf;   Other: Standard dressing regimen
36 Unknown  Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
Condition: Epidermolysis Bullosa Simplex
Interventions: Drug: Dysport® (Botulinumtoxin A (Btx A));   Drug: Placebo
37 Completed Establishment of the National Epidermolysis Bullosa Registry
Condition: Epidermolysis Bullosa
Intervention:
38 Completed Study of the Nutritional, Metabolic, and Body Composition Profile in Children and Adolescents With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention:
39 Completed Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: isotretinoin
40 Completed Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita
Condition: Epidermolysis Bullosa Acquisita
Intervention: Drug: methoxsalen

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-53) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.